Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study (Q84895075)
Jump to navigation
Jump to search
scientific article published on 01 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study |
scientific article published on 01 August 2012 |
Statements
Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study (English)
Ge-Heng Yuan
Wei-Li Song
You-Yuan Huang
Xiao-Hui Guo
1 August 2012